Следене
Thomas A. Munro
Thomas A. Munro
Няма данни за членство
Потвърден имейл адрес: munro.com - Начална страница
Заглавие
Позовавания
Позовавания
Година
Sci-Hub provides access to nearly all scholarly literature
DS Himmelstein, AR Romero, JG Levernier, TA Munro, SR McLaughlin, ...
eLife 7, e32822, 2018
2682018
Studies toward the pharmacophore of salvinorin A, a potent κ opioid receptor agonist
TA Munro, MA Rizzacasa, BL Roth, BA Toth, F Yan
Journal of Medicinal Chemistry 48 (2), 345-348, 2005
1512005
Salvinorins D-F, new neoclerodane diterpenoids from Salvia divinorum, and an improved method for the isolation of salvinorin A
TA Munro, MA Rizzacasa
Journal of Natural Products 66 (5), 703-705, 2003
1162003
Long-acting κ opioid antagonists nor-BNI, GNTI and JDTic: pharmacokinetics in mice and lipophilicity
TA Munro, LM Berry, AV Veer, C Béguin, FI Carroll, Z Zhao, WA Carlezon, ...
BMC Pharmacology 12, 5, 2012
1042012
Divinatorins A-C, new neoclerodane diterpenoids from the controlled sage Salvia divinorum
AK Bigham, TA Munro, MA Rizzacasa, RM Robins-Browne
Journal of Natural Products 66 (9), 1242-1244, 2003
992003
Functional selectivity of 6′-guanidinonaltrindole (6′-GNTI) at κ-opioid receptors in striatal neurons
CL Schmid, JM Streicher, CE Groer, TA Munro, L Zhou, LM Bohn
Journal of Biological Chemistry 288 (31), 22,387-22,398, 2013
982013
Standard protecting groups create potent and selective κ opioids: salvinorin B alkoxymethyl ethers
TA Munro, KK Duncan, W Xu, Y Wang, LY Liu-Chen, WA Carlezon Jr, ...
Bioorganic & Medicinal Chemistry 16 (3), 1279-1286, 2008
882008
N-methylacetamide analog of salvinorin A: A highly potent and selective κ-opioid receptor agonist with oral efficacy
C Beguin, DN Potter, JA DiNieri, TA Munro, MR Richards, TA Paine, ...
The Journal of pharmacology and experimental therapeutics 324 (1), 188-195, 2008
612008
Lack of effect of sublingual salvinorin A, a naturally occurring kappa opioid, in humans: a placebo-controlled trial
JE Mendelson, JR Coyle, JC Lopez, MJ Baggott, K Flower, ET Everhart, ...
Psychopharmacology 214 (4), 933-939, 2011
482011
Salvinorin A and derivatives: protection from metabolism does not prolong short-term, whole-brain residence
JM Hooker, TA Munro, C Béguin, D Alexoff, C Shea, Y Xu, BM Cohen
Neuropharmacology 57 (4), 386-391, 2009
482009
Modification of the furan ring of salvinorin A: identification of a selective partial agonist at the kappa opioid receptor
C Béguin, KK Duncan, TA Munro, DM Ho, W Xu, LY Liu-Chen, ...
Bioorganic & Medicinal Chemistry 17 (3), 1370-1380, 2009
432009
Selective κ opioid antagonists nor-BNI, GNTI and JDTic have low affinities for non-opioid receptors and transporters
TA Munro, XP Huang, C Inglese, MG Perrone, A Van’t Veer, FI Carroll, ...
PLoS ONE 8 (8), e70701, 2013
362013
8-epi-Salvinorin B: crystal structure and affinity at the κ opioid receptor
T Munro, K Duncan, R Staples, W Xu, LY Liu-Chen, C Béguin, ...
Beilstein Journal of Organic Chemistry 3, 1, 2007
272007
Autoxidation of salvinorin A under basic conditions
TA Munro, GW Goetchius, BL Roth, TA Vortherms, MA Rizzacasa
Journal of Organic Chemistry 70 (24), 10,057-10,061, 2005
252005
The chemistry of Salvia divinorum
TA Munro
Dissertation Abstracts International, 2006
182006
Studies toward bivalent κ opioids derived from salvinorin A: heteromethylation of the furan ring reduces affinity
TA Munro, W Xu, DM Ho, LY Liu-Chen, BM Cohen
Beilstein Journal of Organic Chemistry 9, 2916–2924, 2013
132013
Salvinorin derivatives and uses thereof
C Beguin, JS Potuzak, TA Munro, KK Duncan, WA Carlezon, BM Cohen, ...
US Patent 8,492,564, 2013
82013
Salvinorin B methoxymethyl ether
TA Munro, DM Ho, BM Cohen
Acta Crystallographica Section E 68 (11), o3225-o3226, 2012
42012
Reanalysis of a μ opioid receptor crystal structure reveals a covalent adduct with BU72
TA Munro
BMC biology 21, 213, 2023
32023
Revised (β-phenyl) stereochemistry of ultrapotent μ opioid BU72
TA Munro
bioRxiv, http://doi.org/dq7s, 2020
22020
Системата не може да изпълни операцията сега. Опитайте отново по-късно.
Статии 1–20